On May 12th the president signed an executive order that seeks to force drugmakers to reduce their prices in America to align ...

The Trump administration has issued an executive order aimed at lowering drug costs.

Oregon Senator Jeff Merkley is teaming up with three congressional colleagues to introduce a bill aiming to slash ...

Congressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

US President Donald Trump’s latest executive order seeks to slash prices of prescription drugs by 30-80%. The idea behind the ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Codexis reiterated its full-year 2025 financial guidance originally issued on February 27, 2025, as follows: Total revenues are expected to be in the range of $64 million to $68 million.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?

BofA Securities 2025 Healthcare Conference May 14, 2025 1:00 PM ETCompany ParticipantsJeff Stewart - EVP and Chief ...